fashion -WSS

fashion

author：explore 2025-09-27 09:55:18 - browse：73

Stacks of silver coins surrounded by a medicare health insurance card — insurance coverage from STAT — A federal rule that could make Medicare reimbursement for breakthrough devices easier is slated for early summer. Adobe

WASHINGTON — A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, a Centers for Medicare and Medicaid Services official said on Thursday.

The agency has faced intense pressure from device makers frustrated with the slow pace of Medicare reimbursement decisions. Medical technology lobby AdvaMed sent CMS a strongly-worded letter in March asking why it has taken so long to get the breakthrough device program moving.

Dora Hughes, director of the clinical standards center at CMS, told attendees at the Medical Device Manufacturers’ Association conference the agency wanted to take the time to meaningfully address feedback sent during the comment period, which closed in August. She also noted the organization’s goal of releasing the final rule with a slate of other policies, including a rule clarifying the agency’s thinking on what kind of evidence would be needed to convince the agency that a given device is both reasonable and necessary.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

knowledge

WSS

FDA rejects Alnylam's heart disease treatment over insufficient data

Phenylephrine and the overlooked value of the placebo effect

Was Amgen transparent enough on FDA's concern on cancer drug?

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

How to bring more disabled researchers into academia

Sen. Paul opposes bill to ban Chinese biotechs

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

IVF, abortion rights issues kick off Biden’s State of the Union

Alkermes shareholders re

What to expect at HLTH 2023, the health care industry conference

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

AI can decode, harness the power of the humane immune system

Continuity nursing helped my family in our darkest PICU moments

Liquid biopsy for lung cancer is launched by Delfi

Guidelines to prevent youth baseball injuries need more muscle

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

focus

Stroke deaths set to near 10 million globally by 2050

Physician executives need more than on

NEJM study link tiny plastics in blood vessels to heart problems

What it’s like to watch children die of measles

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

IVF, abortion rights issues kick off Biden’s State of the Union

hotspot

knowledge

Wikipedia

focus